Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer

Programmed cell death 1 ligand 1 (PD-L1) has been approved as predictive biomarker for non-small-cell lung cancer (NSCLC) patients treated with PD-(L)1 blockade therapy. The clinical/genomic features associated with PD-L1 are not well studied. Genomic profiling of tumor biopsies from 883 Chinese NSC...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yue, Li, Chong, Jiang, Ya, Han, Xue, Liu, Sisi, Xu, Xiuxiu, Tang, Wanxiangfu, Ou, Qiuxiang, Bao, Hua, Wu, Xue, Shao, Yang, Xing, Minyan, Zhang, Yixiang, Wang, Yuezhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015849/
https://www.ncbi.nlm.nih.gov/pubmed/35444698
http://dx.doi.org/10.1155/2022/1763778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015849/
https://www.ncbi.nlm.nih.gov/pubmed/35444698
http://dx.doi.org/10.1155/2022/1763778

Ejemplares similares